Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...

Diana Taurasi, the WNBA's all-time leading scorer, retired from the Mercury after 20 years with team. Here's why she didn't ...

This article was originally published on www.si.com/high-school as The size of the fight in the Bulldog: Carl Junction senior ...

Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.

Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with ...

Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Blocking structural changes may restore the effectiveness of the cancer drug venetoclax, according to Rutgers Health ...

On Sept. 11, Michigan representatives proposed an internet content ban bill unlike any of the others we've seen: This particularly far-reaching legislation would ban not only many types of online ...